Exemplary cooperation
This vaccine is the product of a strong interaction between a large number of private and state actors. It was developed in Canada under the auspices of that country’s public health agency, with financial support from the United States. The license was given to the company NewLink Genetics (located in Ames, Iowa) which is associated with MSD to ensure the development, manufacture and distribution of the vaccine, MSD retaining the exclusive rights associated with it. The clinical trial itself was designed by a group of experts from seven countries and the WHO. It was carried out in Guinea under the authority of the country’s Ministry of Health and with the help of several international organizations, including the WHO and Médecins sans frontières. This international cooperation has therefore proved to be effective.
1
2
3
4
5
…
for our subscribers,
the article consists of 3 pages
–
The latest events
August 8-28, 2014 West Africa. Worsening of the Ebola fever epidemic
viruses are reported in the Democratic Republic of the Congo. On the 12th, the WHO authorized the use of vaccines and experimental treatments against the Ebola virus, not yet evaluated in humans. On the 28th, while the health ministers of the Economic Community of West African States, meeting in Accra (Ghana), are struggling to adopt measures […]
Read more
–
July 2-3, 2014 West Africa. Ebola fever epidemic
Ebola. Since March, it has already infected seven hundred and fifty people, four hundred and forty-five of whom have died, in Guinea, Liberia and Sierra Leone. There is no vaccine or treatment for this highly contagious virus. The epidemic, the strongest recorded since the discovery of the virus in 1976, continues to progress: we are counting close to […]
Read more
—
